Latest filing published 19 Oct 2022 for Zymergen Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Enakshi Singh: trading record in brief
All filings by Enakshi Singh on record concern Zymergen Inc., in the capacity of finance chief. Over a trading history stretching from 26 October 2021 to 19 October 2022, the count stands at 8 filings.
The open-market record consists of 3 sales worth €54k, with no purchase. Besides market trades, the filings include 3 share grants and 1 option exercise. So far in 2022, the count stands at no purchases and 3 sales.
The latest filing, published on 19 October 2022, reports a transaction in Zymergen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Enakshi Singh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 462,241 sharesCommon StockSEC:0001645842-22-000131:0
- 3,786 shares@ US$2.79925.3% of flowCommon StockSEC:0001645842-22-000128:0
- 3,928 shares@ US$2.214.3% of flowCommon StockSEC:0001645842-22-000126:0
- 15,365 shares@ US$2.274417.1% of flowCommon StockSEC:0001645842-22-000120:0
- 8,320 shares0Common StockSEC:0001645842-22-000116:0
- 250,000 shares0Common StockSEC:0001645842-22-000032:0
- 50,000 shares@ US$1.7058.0% of flowCommon StockSEC:0001645842-21-000044:0
- 77,000 shares0Common StockSEC:0001104659-21-131245:0
8 of 8 declarations
